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study the perioperative mortality rate was the same for
both groups (5.6%). There was no significant difference in
the survival rate between the two groups over a 5-year
period. The incidence of graft failure, however, was signif-
icantly higher in the endoluminal group compared with
the open group.
One of the limitations of that study was the inclusion of
patients undergoing repair with both first- and second-gen-
eration prostheses in the endoluminal group. This led to the
criticism that the 3-year graft success probability of 70% may
not have accurately reflected the results being achieved at
that time with second-generation devices only. A subse-
quent report in which ER by first-generation prostheses was
compared with repair by second-generation prostheses2
confirmed that the outcome analyzed with the life table
method was indeed superior when ER was performed by
second-generation prostheses. A logical extension of these
studies was a comparison of outcome of endoluminal treat-
We have previously reported a concurrent comparison
of endoluminal repair (ER) versus open repair (OR) in the
treatment of abdominal aortic aneurysms (AAAs).1 In that
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Purpose: The aim of this study was to compare the outcome of consecutive patients with abdominal aortic aneurysm
(AAA) treated concurrently by means of open repair (OR) and endoluminal repair (ER) with second-generation pros-
theses by the same surgeons during a defined interval.
Methods: Between May 1995 and December 1998 second-generation (low profile, fully supported, modular) endopros-
theses were implanted in 148 patients. These patients, together with 135 patients treated concurrently with OR during
the same period, comprised the study group of 283 patients. Patient selection was based on aneurysm morphology. Those
patients who were anatomically suitable for ER were treated with this method. The ER and OR groups were similar with
regard to age, sex, and size of AAA. The ER group contained high-risk patients considered unfit for OR (n = 46), and
the OR group contained high-risk patients who were anatomically unsuitable for ER (n = 19). Outcome criteria in both
groups were survival and successful aneurysm repair. Success in the ER group was defined as exclusion of the aneurysm
sac and stability or reduction in AAA maximum transverse diameter. Persistent endoleaks were classified as failures,
regardless of whether they were subsequently corrected with secondary endovascular intervention. Data were analyzed
with the life table method. The minimum period of follow-up for all patients was 18 months.
Results: The perioperative mortality rate was 5.9% in the OR group and 2.7% in the ER group (not significant). There
was a statistically significant difference between the survival curves of the two groups in favor of the ER group when
analyzed with the log-rank test (P = .004). The Kaplan-Meier curve for graft failure for the ER group revealed a 3-year
graft success probability of 82%. Survival probability with successful repair in the OR group at 3 years was 85%.
Conclusions: A concurrent comparison of ER with second-generation prostheses versus OR demonstrated a significant
difference in survival in favor of the ER group. The probability of survival with successful repair at 3 years was similar
in both groups. (J Vasc Surg 2001;33:S21-6.)
ment of AAA by second-generation prostheses with that of a
concurrent control group that underwent OR, in consecu-
tive patients. We present such a concurrent comparison with
analysis with the life table method over a 5-year period.
METHODS
Between May 1992 and December 1998, 540 consec-
utive patients with nonruptured AAA underwent elective
repair at the Royal Prince Alfred Hospital. The open
method (OR) was used in 274 patients, and the endolumi-
nal method (ER) was used in 266 patients. Second-genera-
tion endoprostheses were introduced in mid 1995. These
were characterized by a low profile (21F or less) delivery
system and a modular endograft fully supported throughout
its length by a self-expanding metallic frame. Between May
1995 and December 1998 these second-generation devices
were implanted in 148 patients. These patients, together
with 135 patients treated concurrently with OR during the
same period by the same surgeons, comprised the study
group of 283 patients.
Patient selection was based on aneurysm morphology.
Detailed imaging with contrast-enhanced computed
tomography (CT) and aortography was performed before
surgery in all patients. Anatomic criteria for endoluminal
grafting based on these investigations included
1. a proximal aneurysm neck with a 15-mm length or
greater and a diameter of 28 mm or less, 
2. a proximal neck angulation less than 75 degrees,
3. no evidence of a patent inferior mesenteric artery,
4. iliac arteries with a degree of calcification, tortuosity,
and diameter that was not considered to be an imped-
iment to the passage of the delivery catheter.
Those patients who were anatomically suitable for ER
were treated with this method.
ER group. Prospective data were recorded for 148 con-
secutive patients who underwent ER with second-generation
prostheses. The group comprised 137 male patients and 11
female patients with a mean age of 72 years. Comorbidities
sufficiently severe to preclude OR were present in 46 patients
(Table I). Twenty-seven patients had medical conditions in
addition to the comorbidities that excluded them from OR.
These medical conditions are summarized in Table II.
Technique of endoluminal aneurysm repair. The
program of endoluminal grafting was approved by the
Institutional Research Review Board and Ethics
Committee. Informed consent was obtained from each
patient. All procedures were performed in the operating
room with patients prepared and draped for conventional
open operation in the event that conversion was required
or serious complications occurred. The endografts used
were Stentor/Vanguard (Boston Scientific, Natick, Mass)
(69), AneuRx (Medtronic AVE, Santa Rosa, Calif) (55),
Talent (Medtronic AVE, Santa Rosa, Calif) (10), Baxter
(Irvine, Calif) (8), Bard (Haverhill, Mass) (5), and Gore
(Flagstaff, Ariz) (1). Prophylactic antibiotics were admin-
istered at the time of induction of anesthesia, and all
patients were anticoagulated with 5000 units of heparin
administered intravenously. Monitoring of the anticoagu-
lation status was not used. Access was gained by exposing
the common femoral arteries bilaterally through small
incisions. The techniques used for deployment of the
endoprostheses have been described in detail previously.3
Fluoroscopic monitoring was used in the delivery and
deployment of all endografts. On-table completion
angiography was undertaken in all patients.
Follow-up. Contrast-enhanced CT was performed
before discharge, at 6 months, 12 months, 18 months,
and annually thereafter. Most of these investigations were
performed at our institution. Those that were not were
done at our direction, and the resulting scans viewed by
us. Outcome measures for this study were survival and
successful outcome after primary AAA repair. Success was
defined as exclusion of the aneurysm sac from the circula-
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Table I. Comorbidities of patients who underwent ER
of AAA
No.
Severe cardiac disease
ASA stage 3b or 4 22
Renal failure
Successfully transplanted 1
Severe respiratory disease 10
Boushy category III*
Chronic liver disease
Cirrhosis/portal hypertension 2
Childs’ category A or B†
Hostile abdomen‡ 11
Total 46
*Boushy: Classification of grade of dyspnea modified and
reported in “Anesthetic Implications of Concurrent Diseases.”4
†Childs’ criteria for hepatic functional reserve.
‡Causes of hostile abdomen: previous abdominal irradiation (2);
inflammatory AAA (3); stoma and adhesions (5); ileal bladder (1).
AAA, Abdominal aortic aneurysm; ASA, American Society of
Anesthetists; ER, endoluminal repair.
Table II. Characteristics of patients undergoing ER and
OR AAA 
ER OR
Mean age (y) 72 69
Sex (M/F) 11/137 23/112
Diameter AAA mean (range) in cm (3-9-8) (4-7-9.5)*
Ischemic heart disease (%) 83 (56) 69 (51)
Hypertension (%) 52 (35) 45 (33)
Diabetes mellitus (%) 10 (7) 11 (8)
Renal impairment (%) 12 (8) 5 (4)
Current smoker (%) 27 (18) 31 (23)
*Those aneurysms with the smallest diameters were
saccular/symptomatic.
AAA, Abdominal aortic aneurysms; ER, endoluminal repair; F,
female; M, male; OR, open repair. 
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tion, and stability or reduction in AAA maximum trans-
verse diameter. Persistent endoleak was classified as a fail-
ure, regardless of whether successful secondary ER was
subsequently achieved. Spontaneous seal of an endoleak
with demonstrated consistent reduction in maximum
transverse diameter was classified as a success.
OR group. Elective conventional OR operations were
performed in 135 patients. Of these, 112 were male and
23 were female with a mean age of 69 years. Patient char-
acteristics of the group are summarized in Table II. The
OR group contained 19 patients who were regarded as
high risk and were anatomically unsuitable for ER. These
were patients who were classified as category III by the
American Society of Anesthetists whose cardiac disease
status could not be improved by intervention (5), patients
with severe respiratory disease, patients classified as
Boushy category 2 (3),4 and patients with hostile
abdomen (6), gross obesity (4), and renal failure while
undergoing dialysis (1).
Technique of open aneurysm repair. A conventional
technique of open AAA repair with a midline transperi-
toneal approach was used. Other measures included rou-
tine use of prophylactic antibiotics, systemic heparin
anticoagulation (5000 units given intravenously) at the
time of cross-clamping, and postoperative ventilation and
monitoring in the intensive care unit.
Follow-up. Follow-up was conducted by means of an
interview with the patient, examination, and telephone
conversations. The New South Wales Department of
Births, Deaths, and Marriages confirmed the date and
cause of death in seven patients who had not previously
been able to be traced.
RESULTS
Endoluminal group. ER was achieved in 147 (99%)
of 148 patients. Conversion to OR was required in the
remaining patient, who sustained a perforation of the
common iliac artery. Secondary conversion to OR on a
subsequent occasion was required in four patients. The
causes of these secondary conversions were ruptured AAA
in two patients, 19 and 30 months after ER; inadvertent
covering of the renal arteries with the endograft in one
patient; and increasing aneurysm diameter in another
patient. In this last patient mentioned, completion angiog-
raphy, discharge CT scan, and follow-up CT at 6, 12, 18,
and 24 months showed exclusion of the AAA without evi-
dence of endoleak. Initially, the aneurysm shrank. However,
at 24 months, the diameter had increased by 1.6 cm, and
the aneurysm had once again become pulsatile. Abdominal
radiographs and angiography indicated downward displace-
ment of the proximal end of the prosthesis, but there was
no radiologic evidence of endoleak. The patient was con-
verted from ER to OR. At operation the pressure in the
aneurysm sac was measured and found to be similar to the
systolic pressure. No recent red clot was noted in the sac.
The maximum transverse diameter either decreased or
remained stable in the rest of the endoluminal group.
Four perioperative deaths occurred in 148 (2.7%)
patients. Acute renal failure was the major cause of death in
two patients, one of whom had inadvertently had both
renal arteries covered by the endograft. Acute myocardial
infarction resulted in death in the third patient, and the
fourth death resulted from sigmoid volvulus after the
patient was discharged from the hospital and within 30
days of the operation. There was one late death due to con-
gestive cardiac failure and renal failure. Local/vascular
complications and remote/systemic complications are
listed in Tables III and IV.
Late endoleaks. Late endoleaks occurred in eight
patients. The type of endoleak, the time of onset after ER,
and the management are shown in Table V.
OR group. Eight perioperative deaths occurred in
135 patients who underwent OR. Five were caused by
myocardial infarction, two by renal failure, and one by
pneumonia and septicemia. Eleven late deaths occurred in
the OR group. These were caused by myocardial infarc-
tion (4); ischemic heart disease leading to pulmonary
edema (1) and cardiac arrest (1); metastatic carcinoma
from the lung (1) and the uterus (1); and chronic renal
failure, pneumonia, and cerebral hemorrhage in the remain-
Table III. Local/vascular complications of ER of AAA
No. %
Perforation of iliac artery 1 0.7
Lower limb ischemia
Acute 13* 9
Chronic 4 3
Endoleak
Perioperative 10 7
Late 8 5
Endotension 1 0.7
Renal arteries covered 1 0.7
Wound complications 4 3
Total 45 30
*Includes iatrogenic injury to access arteries (4), peripheral
embolization (3), and graft limb/native iliac artery thrombosis (6).
Table IV. Remote/systemic complications of ER of AAA
No. %
Renal insufficiency
Renal artery ostia obstructed 1 0.7
Contrast media-induced* 3 2
Cardiac
Congestive failure 4 3
Myocardial infarction 3 2
Cardiac arrhythmia 2 1
Stroke/TIA 1 0.7
Total 14 9
*Serum creatinine level > 200 mmol/L.
ER, Endoluminal repair; TIA, transient ischemic attack.
JOURNAL OF VASCULAR SURGERY
S24 May et al February 2001
ing three patients. There were no instances of graft failure
in the open group. Local/vascular and remote/systemic
complications are listed in Table VI.
Comparison of outcome. The perioperative mortal-
ity rate in the OR group was 5.9% (8/135). This was not
significantly different from the perioperative mortality rate
of 2.7% (4/148) in the ER group.
Patient survival curves for both groups are shown in
Fig 1. A statistically significant difference existed between
these curves (P = .004, log-rank test) with the endolumi-
nal group having a superior survival rate. The survival
probability at 3 years for the endoluminal group was 96%
and 85% for the open group. The overall median follow-
up time was 29 months, with a median follow-up of 24
months in the endoluminal group and 37 months in the
open group. No patients were lost to follow-up. (See sur-
vival analysis table online for data.)
Graft failure. The incidence of graft failure was sig-
nificantly higher in the endoluminal group (22 of 148)
compared with the open group (0 of 135) (Fisher exact
test, P < .0001; Table VII).
The causes of graft failure in 22 patients in the endo-
luminal group were iliac artery perforation resulting in pri-
mary conversion (1), secondary conversion (4) (detailed
in the “Results” section), and persistent endoleaks (17).
The eighteenth patient with persistent endoleak listed in
Table III presented with rupture and underwent success-
ful conversion to OR. This failure has been included under
the category of secondary conversion. Although nine of
Table VI. Complications of OR of AAA
No. %
Local/vascular
Abdominal wound dehiscence 2 1
Bowel obstruction 1 0.7
Peripheral embolization 2 1
Wound infection 4 3
Total 9 7
Remote/systemic
Renal
Acute renal failure 6 4
Cardiac
Congestive failure 6 4
Myocardial infarction 7 5
Cardiac arrhythmia 5 4
Stroke/TIA 2 1
Total 26 19
OR, Open repair; TIA, transient ischemic attack.
Fig 1. Kaplan-Meier curves for survival after ER and OR of AAA. Statistically significant difference existed between these curves with
endoluminal group having superior survival rate.
Table V. Late endoleaks after ER of AAA
Type of Time of 
Patient endoleak onset (mo) Treatment
1 II IMA 6 Coil embolization
2 II lumbar 12 Coil embolization
3 II lumbar 18 Observation
4 III limb dislocation 12 Endovascular repair
5 I proximal 20 Cuff deployment
6 I proximal 3 Cuff deployment
7 I distal 12 Limb extension
8 I distal 36 Limb extension
ER, Endoluminal repair; IMA, inferior mesenteric artery.
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the previously mentioned 17 patients with endoleak have
undergone successful secondary ER, they have been clas-
sified as failures in this study, which is limited to primary
success and not assisted success. The Kaplan-Meier curve
for graft failure times for the endoluminal group revealed
a 3-year graft success probability of 82% (Fig 2). The rel-
ative incidence of graft failure for the three most com-
monly used prostheses was 11 (20%) of 54 (Vanguard), 2
(13%) of 15 (Stentor), and 6 (11%) of 55 (AneuRx).
DISCUSSION
The outcome from this study differs from the previous
report1 in that the difference in survival between the open
and the endoluminal group is statistically significant in
favor of the endoluminal group. It should be pointed out,
however, that the late deaths occurring in the open group
resulted from medical conditions unrelated to aneurysm
repair. The graft success probability at 3 years in the cur-
rent report of 82% is better than the previous report of
71%. The probability of survival with a functioning graft at
3 years in the open group is 85% compared with 82% for
the endoluminal group.
The limitations of this study must be acknowledged.
The retrospective analysis of the data for the open group
may have underestimated the incidence of complications
in this group. In a CT follow-up on a cohort of patients
enrolled in the Canadian Aneurysm Study, Kalman et al5
found aneurysmal dilatation of the cuff between the renal
arteries and graft more than 3 cm in diameter in 5.3% and
the presence of a false aneurysm in this site in 7.5%
between 8 and 9 years from operation. Regular follow-up
and use of contrast-enhanced CT in the endoluminal
group make it highly unlikely that any failures or compli-
cations would be overlooked. The open group was not
subjected to such scrutiny. This may account for the dis-
parate incidence rates of local vascular complications after
ER and OR in this study and that of others.6 A further
limitation of this study concerns the possibility of deaths
in high-risk patients weighting the outcome and creating
a false difference between the two survival curves. This
seems unlikely because the proportion of high-risk
patients in the endoluminal group was 46 (31%) of 148
and in the open group, 19 (14%) of 135. Thus, any bias
toward a poor outcome would be greater in the endolu-
minal group, which in fact, had a superior survival rate
compared with the open group.
The difference in the median follow-up times in the
two treatment groups requires comment. This resulted
from a progressive increase in the proportion of patients
Table VII. Graft failure
Endoluminal Open Total
Successful repair 126 135 261
Failed repair 22 0 22
Total 148 135 283
Fisher exact test, P < .0001.
Fig 2. Kaplan-Meier curve for graft failure times for endoluminal group.
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treated with the endoluminal method compared with the
open method throughout the 3.5-year period of recruit-
ment. As a result the endoluminal group as a whole had a
shorter follow up.
Considering that the natural history of AAA involves
progressive expansion with consequent neck angulation
and iliac artery tortuosity in addition to progressive
aneurysm degeneration in the proximal neck, one might
anticipate that patients who were anatomically unsuitable
for ER would represent a more advanced form of
aneurysm disease. We found no evidence that patients who
were anatomically unsuited for ER were in any way at
greater risk from an OR compared with a historic control
group who were anatomically suitable for ER but treated
with OR.7
The incidence of graft failure after ER was similar in
the three most commonly used prostheses: Vanguard,
Stentor, and AneuRx. The highest incidence in Vanguard
devices was related to longer follow-up than in AneuRx
devices and the penalty of failure resulting from two Type
II endoleaks. These collateral-related endoleaks are cor-
rectly classified as failures but are not device related.
One patient in whom the maximum transverse diame-
ter of AAA increased despite exclusion of the aneurysm
from the circulation was considered to have endotension
and has been reported together with three others, by us.8
Persistent sac pressurization indicated by continued AAA
growth is thought to result from pressure transmission
from the aortic lumen to the AAA sac contents through
the thrombus, in this patient whose prosthesis had
migrated without evidence of endoleak.
This study has demonstrated a statistically significant
difference in survival between the two groups, with the
endoluminal group having a superior survival rate. The
difference in the incidence of graft failure between the two
groups was also significant with the open group having a
lower incidence of graft failure. These two factors have
resulted in the probability of survival with a functioning
graft at 3 years being similar in both treatment groups
(OR, 85%; ER, 82%).
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